TOP 100 WEIGHT LOSS SITES
| |||
|
| |||
| |||
|
| |||
| Merck Discontinues Development Of Investigational Medicine Taranabant For Obesity Merck & Co., Inc. will not seek regulatory approval for taranabant, an investigational medicine, to treat obesity and is discontinuing its Phase III clinical development program for taranabant for obesity. "Available Phase III data showed that both efficacy and adverse events were dose related, with greater efficacy and more adverse events in the higher doses. medicalnewstoday.com |
Free Online Tool From The Dairy Council Of California Increases Physical Activity New research suggests that a healthier, more physically active lifestyle is just a few clicks away with Dairy Council of California's MyFitness Planner. Regular physical activity can reduce the risk of chronic diseases like type 2 diabetes, heart disease and cancer, yet less than half of all American women (47.7 percent) engage in at least 30 minutes of moderate-intensity or greater physical activity on most days of the week. medicalnewstoday.com |
The Clinically Proven Weight Loss Treatment Alli(R) (orlistat 60 Mg) Is Now On Sale In Pharmacies, Europe GlaxoSmithKline (GSK) announces that alli - the weight loss treatment that could help adults with BMI of 28 kg/m2 or more, lose 50 per cent more weight than by dieting alone1 - goes on sale today in pharmacies throughout the UK, and in markets throughout Europe during April and May. For every 2 kilos lost using a reduced calorie, lower-fat diet, an extra 1 kilo could be lost by using alli. medicalnewstoday.com |
Physical Activity In Children Improves Their Sleeping Patterns A research published ahead of print in the Archives of Disease in Childhood reports that every hour of the day children are inactive adds three minutes to the time it takes them to fall asleep. The study indicates that children who fall asleep faster also sleep for longer. Although, it appears one is not the direct consequence of the other. medicalnewstoday.com |
Side Effects Of Stereotactic Body Radiation Therapy In Lung Cancer Patients Significantly Increased By Obesity Obesity, not the amount of radiation given, is the greatest factor in whether early-stage lung cancer patients develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, with obese patients being more than twice as likely to develop chronic pain compared to those who have less body weight, according to a first-of-its-kind study presented Tuesday, November 3, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). medicalnewstoday.com |